Theralase Technologies OTC Stock Forecast - Naive Prediction
| TLTFF Stock | USD 0.18 0.02 10.00% |
The Naive Prediction forecasted value of Theralase Technologies on the next trading day is expected to be 0.19 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.48. Theralase OTC Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Theralase Technologies' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 22nd of January 2026, The value of RSI of Theralase Technologies' share price is at 59. This usually implies that the otc stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Theralase Technologies, making its price go up or down. Momentum 59
Buy Extended
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Theralase Technologies based on different types of headlines from major news networks to social media. Using Theralase Technologies hype-based prediction, you can estimate the value of Theralase Technologies from the perspective of Theralase Technologies response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Theralase Technologies on the next trading day is expected to be 0.19 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.48. Theralase Technologies after-hype prediction price | USD 0.18 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Theralase |
Theralase Technologies Additional Predictive Modules
Most predictive techniques to examine Theralase price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Theralase using various technical indicators. When you analyze Theralase charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Theralase Technologies Naive Prediction Price Forecast For the 23rd of January
Given 90 days horizon, the Naive Prediction forecasted value of Theralase Technologies on the next trading day is expected to be 0.19 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.0001, and the sum of the absolute errors of 0.48.Please note that although there have been many attempts to predict Theralase OTC Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Theralase Technologies' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Theralase Technologies OTC Stock Forecast Pattern
| Backtest Theralase Technologies | Theralase Technologies Price Prediction | Buy or Sell Advice |
Theralase Technologies Forecasted Value
In the context of forecasting Theralase Technologies' OTC Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Theralase Technologies' downside and upside margins for the forecasting period are 0 and 7.68, respectively. We have considered Theralase Technologies' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Theralase Technologies otc stock data series using in forecasting. Note that when a statistical model is used to represent Theralase Technologies otc stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 108.9152 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0078 |
| MAPE | Mean absolute percentage error | 0.0569 |
| SAE | Sum of the absolute errors | 0.4778 |
Predictive Modules for Theralase Technologies
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Theralase Technologies. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Theralase Technologies After-Hype Price Prediction Density Analysis
As far as predicting the price of Theralase Technologies at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Theralase Technologies or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Theralase Technologies, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Theralase Technologies Estimiated After-Hype Price Volatility
In the context of predicting Theralase Technologies' otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Theralase Technologies' historical news coverage. Theralase Technologies' after-hype downside and upside margins for the prediction period are 0.01 and 7.67, respectively. We have considered Theralase Technologies' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Theralase Technologies is out of control at this time. Analysis and calculation of next after-hype price of Theralase Technologies is based on 3 months time horizon.
Theralase Technologies OTC Stock Price Prediction Analysis
Have you ever been surprised when a price of a OTC Stock such as Theralase Technologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Theralase Technologies backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Theralase Technologies, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.68 | 7.49 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.18 | 0.18 | 0.00 |
|
Theralase Technologies Hype Timeline
Theralase Technologies is at this time traded for 0.18. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Theralase is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.68%. %. The volatility of related hype on Theralase Technologies is about 0.0%, with the expected price after the next announcement by competition of 0.18. The company recorded a loss per share of 0.02. Theralase Technologies had not issued any dividends in recent years. Assuming the 90 days horizon the next forecasted press release will be within a week. Check out Historical Fundamental Analysis of Theralase Technologies to cross-verify your projections.Theralase Technologies Related Hype Analysis
Having access to credible news sources related to Theralase Technologies' direct competition is more important than ever and may enhance your ability to predict Theralase Technologies' future price movements. Getting to know how Theralase Technologies' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Theralase Technologies may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RDGL | Vivos Inc | 0.00 | 0 per month | 5.66 | (0.01) | 8.89 | (7.69) | 32.50 | |
| NVYTF | Novacyt SA | 0.00 | 0 per month | 0.00 | (0.21) | 0.00 | 0.00 | 7.88 | |
| DSOL | Drug Free Solution | 0.00 | 0 per month | 0.00 | 0.1 | 0.00 | 0.00 | 27.27 | |
| ELXMF | Nova Eye Medical | 0.00 | 0 per month | 0.00 | (0.13) | 0.00 | 0.00 | 98.10 | |
| CYYNF | Cynata Therapeutics Limited | 0.00 | 0 per month | 0.00 | 0.09 | 0.00 | 0.00 | 25.00 | |
| MMIRF | MedMira | 0.00 | 0 per month | 0.00 | (0.03) | 0.00 | 0.00 | 169.05 | |
| SEOVF | Sernova Corp | 0.00 | 0 per month | 4.54 | 0.01 | 10.00 | (9.09) | 28.33 | |
| BIOQ | Bioqual | 0.00 | 0 per month | 0.00 | (0.35) | 0.00 | 0.00 | 3.73 | |
| PETV | PetVivo Holdings | 0.00 | 0 per month | 0.00 | (0.10) | 7.55 | (9.82) | 32.58 | |
| MDDVF | Medical Developments International | 0.00 | 0 per month | 0.00 | 0.06 | 0.00 | 0.00 | 23.33 |
Other Forecasting Options for Theralase Technologies
For every potential investor in Theralase, whether a beginner or expert, Theralase Technologies' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Theralase OTC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Theralase. Basic forecasting techniques help filter out the noise by identifying Theralase Technologies' price trends.Theralase Technologies Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Theralase Technologies otc stock to make a market-neutral strategy. Peer analysis of Theralase Technologies could also be used in its relative valuation, which is a method of valuing Theralase Technologies by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Theralase Technologies Market Strength Events
Market strength indicators help investors to evaluate how Theralase Technologies otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Theralase Technologies shares will generate the highest return on investment. By undertsting and applying Theralase Technologies otc stock market strength indicators, traders can identify Theralase Technologies entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.9 | |||
| Day Median Price | 0.18 | |||
| Day Typical Price | 0.18 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.02) | |||
| Relative Strength Index | 59.45 |
Theralase Technologies Risk Indicators
The analysis of Theralase Technologies' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Theralase Technologies' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting theralase otc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.83 | |||
| Semi Deviation | 5.05 | |||
| Standard Deviation | 7.46 | |||
| Variance | 55.71 | |||
| Downside Variance | 98.73 | |||
| Semi Variance | 25.53 | |||
| Expected Short fall | (10.61) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Theralase Technologies
The number of cover stories for Theralase Technologies depends on current market conditions and Theralase Technologies' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Theralase Technologies is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Theralase Technologies' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in Theralase OTC Stock
Theralase Technologies financial ratios help investors to determine whether Theralase OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Theralase with respect to the benefits of owning Theralase Technologies security.